| MeSH term | MeSH ID | Detail |
|---|---|---|
| Candidemia | D058387 | 2 associated lipids |
| Blastomycosis | D001759 | 5 associated lipids |
| Aspergillosis | D001228 | 5 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Xerostomia | D014987 | 6 associated lipids |
| Gonorrhea | D006069 | 7 associated lipids |
| Candidiasis, Vulvovaginal | D002181 | 8 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Urethritis | D014526 | 9 associated lipids |
| AIDS-Related Opportunistic Infections | D017088 | 9 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Al-Jubory AR and Handy RD | Uptake of titanium from TiOâ‚‚ nanoparticle exposure in the isolated perfused intestine of rainbow trout: nystatin, vanadate and novel COâ‚‚-sensitive components. | 2013 | Nanotoxicology | pmid:23020080 |
| Marmiroli M et al. | A genome-wide nanotoxicology screen of Saccharomyces cerevisiae mutants reveals the basis for cadmium sulphide quantum dot tolerance and sensitivity. | 2016 | Nanotoxicology | pmid:25938282 |
| Bhattacharya S et al. | DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis. | 2012 | Nano Lett. | pmid:22375622 |
| FEINGOLD DS | ANTIMICROBIAL CHEMOTHERAPEUTIC AGENTS: THE NATURE OF THEIR ACTION AND SELECTIVE TOXICITY. | 1963 | N. Engl. J. Med. | pmid:14050990 |
| Dismukes WE et al. | A randomized, double-blind trial of nystatin therapy for the candidiasis hypersensitivity syndrome. | 1990 | N. Engl. J. Med. | pmid:2247104 |
| Bennett JE | Searching for the yeast connection. | 1990 | N. Engl. J. Med. | pmid:2247107 |
| Casalaz D | Fluconazole prophylaxis against fungal infection in preterm infants. | 2002 | N. Engl. J. Med. | pmid:12066811 |
| A controlled trial of nystatin for the candidiasis hypersensitivity syndrome. | 1991 | N. Engl. J. Med. | pmid:2027363 | |
| Wade JC et al. | A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. | 1981 | N. Engl. J. Med. | pmid:6782486 |
| Abu-Elteen KH | Incidence and distribution of Candida species isolated from human skin in Jordan. | 1999 | Mycoses | pmid:10424102 |
| Messier C and Grenier D | Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. | 2011 | Mycoses | pmid:21615543 |
| Fernández-Campos F et al. | Evaluation of novel nystatin nanoemulsion for skin candidosis infections. | 2013 | Mycoses | pmid:22574899 |
| Blaschke-Hellmessen R and Schwarze U | Bioassay for determination of nystatin in faeces after oral application. | 1990 | Mycoses | pmid:2113608 |
| Monteiro DR et al. | Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms. | 2013 | Mycoses | pmid:23773119 |
| Ellepola AN et al. | The postantifungal effect of nystatin and its impact on adhesion attributes of oral Candida dubliniensis isolates. | 2014 | Mycoses | pmid:23773155 |
| Li D et al. | Efficacy and safety of probiotics in the treatment of Candida-associated stomatitis. | 2014 | Mycoses | pmid:23952962 |
| Preissner S et al. | Adjuvant antifungal therapy using tissue tolerable plasma on oral mucosa and removable dentures in oral candidiasis patients: a randomised double-blinded split-mouth pilot study. | 2016 | Mycoses | pmid:26932256 |
| Blaschke-Hellmessen R et al. | [Effect of orally administered polyene antimycotics on the intestinal colonization with yeasts: possibilities and limitations]. | 1996 | Mycoses | pmid:8767267 |
| Knoke M | [Clinical pictures of orointestinal candidiasis. Fiction or reality?]. | 1996 | Mycoses | pmid:8767268 |
| Kunzelmann V et al. | [Prerequisites for effective therapy of chronic recurrent vaginal candidiasis]. | 1996 | Mycoses | pmid:8767274 |